In conclusion, our findings demonstrate the therapeutic potential of tryptamine, a bacterial tryptophan metabolite, in ameliorating obesity and insulin resistance by regulating lipogenesis and lipolysis in adipose tissue. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.